 |
DHA spearheads breast cancer campaignDubai Health Authority has joined forces with pharma group Sanofi and technology giant Philips to launch its breast cancer awareness campaign which will run till the end of this month. As part of the initiative, free screenings wi More… |
 |
Mobily, Sanofi in Saudi mHealth tieupSaudi telecom services operator Etihad telecom (Mobily) has joined hands with Sanofi, a global health care leader to boost its mobilized healthcare services (mHealth) with an innovative approach. Sanofi and Mobily said the p More… |
 |
Sanofi says MS treatment reduced relapse rateSanofi said on Friday a trial of its multiple-sclerosis treatment teriflunomide found that a daily dose of the drug reduced the rate of relapse by 36 per cent compared with a placebo. Teriflunomide, marketed as Aubagio, is one of the two m More… |
 |
Sanofi strong in emerging markets as rivals flagFrench drugmaker Sanofi posted better-than-expected quarterly results, bolstered by strong emerging markets, breaking with a trend of earnings misses by European rivals AstraZeneca and GlaxoSmithkline. Sanofi performed strongly in Chi More… |
 |
Hospital marks recovery of cancer patientsThe Dubai Hospital recently held an event to mark the recovery of 450 cancer patients aged 2 to 22 years. Hussain Abdul Rehman, medical director of Dubai Hospital said: “This is a tough battle and each of these patients and their family me More… |
 |
Call to set up GCC cancer registryThe Gulf Federation for Cancer Control (GFFCC), along with various health authorities across the GCC, has called for a region-wide cancer registry to help improve research and cancer care in the region. GFCC said the registry will make ava More… |
 |
Sanofi hunts for drugs against hearing lossFrench drugmaker Sanofi said on Thursday it was starting a hunt for medicines to treat hearing loss, after signing a two-year research deal with privately held Dutch biotech firm Audion Therapeutics. There are currently no disease-modifyin More… |
 |
Sanofi diabetes drug ‘cuts blood sugar, weight’Sanofi's candidate drug Lyxumia or lixisenatide, added to basal insulin, significantly reduced blood sugar levels in type 2 diabetes patients and also led to a loss in weight, data published on Tuesday showed. Lixisenatide belongs to the G More… |
 |
US sees no problem with Pfizer, Sanofi vaccinesUS health agencies "have not detected new safety concerns or unusual reporting patterns" in children given Pfizer or Sanofi Aventis vaccines to prevent meningitis and pneumonia, a Food and Drug Administration spokeswoman said. The FDA and More… |
 |
Japan halts vaccines after 4 children dieJapan's health ministry has halted the use of vaccines made by Pfizer and Sanofi-Aventis to prevent meningitis and pneumonia following the deaths of four children. The infants died shortly after receiving the vaccines an More… |
